These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33114221)

  • 1. Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro.
    Hwangbo H; Kim MY; Ji SY; Kim SY; Lee H; Kim GY; Park C; Keum YS; Hong SH; Cheong J; Choi YH
    Antioxidants (Basel); 2020 Oct; 9(11):. PubMed ID: 33114221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
    Sui YH; Luo WJ; Xu QY; Hua J
    World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress.
    Zilu S; Qian H; Haibin W; Chenxu G; Deshuai L; Qiang L; Linfeng H; Jun T; Minxuan X
    Aging (Albany NY); 2019 Dec; 11(24):12177-12201. PubMed ID: 31841118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
    Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
    World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
    Lebeaupin C; Vallée D; Rousseau D; Patouraux S; Bonnafous S; Adam G; Luciano F; Luci C; Anty R; Iannelli A; Marchetti S; Kroemer G; Lacas-Gervais S; Tran A; Gual P; Bailly-Maitre B
    Hepatology; 2018 Aug; 68(2):515-532. PubMed ID: 29457838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
    Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
    Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
    Liu J; Wang T; He K; Xu M; Gong JP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways.
    Lv Y; Gao X; Luo Y; Fan W; Shen T; Ding C; Yao M; Song S; Yan L
    J Nutr Biochem; 2019 Sep; 71():110-121. PubMed ID: 31325892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the effect of liraglutide on the correlation between NLRP3 inflammasome and non-alcoholic fatty liver disease].
    Ma ZZ; Ao N; Yang N; Yang J; Jin S; Du C; Du J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):624-630. PubMed ID: 36038324
    [No Abstract]   [Full Text] [Related]  

  • 12. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.
    Yang G; Lee HE; Lee JY
    Sci Rep; 2016 Apr; 6():24399. PubMed ID: 27075683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice.
    Sun CC; Zhang CY; Duan JX; Guan XX; Yang HH; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX; Liu SK; Zhang J
    Biochem Biophys Res Commun; 2020 Mar; 523(4):1020-1026. PubMed ID: 31973813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice.
    Lu Z; Liu L; Zhao S; Zhao J; Li S; Li M
    Sci Rep; 2023 May; 13(1):7996. PubMed ID: 37198205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet.
    Zhu W; Feng PP; He K; Li SW; Gong JP
    Biochem Biophys Res Commun; 2018 Oct; 505(2):523-529. PubMed ID: 30269815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.
    Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M
    Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice.
    Meng LC; Zheng JY; Qiu YH; Zheng L; Zheng JY; Liu YQ; Miao XL; Lu XY
    Int Immunopharmacol; 2022 Oct; 111():109099. PubMed ID: 35932615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
    Chen HW; Yen CC; Kuo LL; Lo CW; Huang CS; Chen CC; Lii CK
    Toxicol Appl Pharmacol; 2020 Apr; 393():114941. PubMed ID: 32126212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-κB/NLRP3 inflammasome-mediated hepatic inflammation in mice.
    Zou J; Yan C; Wan JB
    Chin Med; 2022 Jan; 17(1):17. PubMed ID: 35078487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.